Sylvia Bartel - Concepedia

Author

Sylvia Bartel

Dana-Farber Cancer Institute

Also Known As

S Bartel, S. Bartel, Sylvia B. Bartel, Sylvia Bartel

Publications

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital Harvard University Rutgers Cancer Institute Dana-Farber/Harvard Cancer Center

About

Sylvia Bartel is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	295
2	Business	1	1	44
3	Education	1	1	44
4	Health Sciences	1	1	98
5	Management	1	1	44

Sylvia Bartel

Publications

927

Citations

H-Index

Page 1

	Year	Citations
Medication safety in the ambulatory chemotherapy setting Tejal K. Gandhi, Sylvia Bartel, Lawrence N. Shulman, Cancer	2005	190
Lack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine Tumors Andrea M. McCollum, Matthew H. Kulke, David P. Ryan, American Journal of Clinical Oncology	2004	121
Oral chemotherapy safety practices at US cancer centres: questionnaire survey Saul N. Weingart, Jonathan A. Flug, Daniela Brouillard, BMJ	2007	109
ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy Barry R. Goldspiel, James M. Hoffman, Niesha Griffith, American Journal of Health-System Pharmacy Ashp GuidelinesPharmacotherapyMetronomic ChemotherapyPre-clinical PharmacologyOncology	2015	98
A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin. Eric H. Rubin, V Wood, Ajit Bharti, PubMed Pharmacokinetic StudyPharmacotherapyDose-limiting ToxicityPharmaceutical ChemistryDrug Resistance	1995	89
Medication errors involving oral chemotherapy Saul N. Weingart, Julio Toro, Justin Spencer, Cancer	2010	85
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma Bryan M. Burt, William G. Richards, Hyun‐Sung Lee, Journal of Thoracic Oncology Intraoperative Hyperthermic CisplatinSurgical OncologySurgical ResectionMedicinePleural Disease	2018	56
Denosumab in hypercalcemia of malignancy: A case series Amanda Dietzek, Kelly Connelly, Michael Cotugno, Journal of Oncology Pharmacy Practice	2014	52
Creating a Fair and Just Culture: One Institution’s Path Toward Organizational Change Maureen Connor, Deborah Duncombe, Emily Barclay, The Joint Commission Journal on Quality and Patient Safety CultureBusiness CultureOrganization DevelopmentChange ManagementManagement	2007	44
Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs Sylvia Bartel, Timothy Tyler, Luci A. Power American Journal of Health-System Pharmacy	2018	31

Page 1